Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.